IS3788A7 - Methods for the preparation of solid dosage forms containing almokalant - Google Patents
Methods for the preparation of solid dosage forms containing almokalantInfo
- Publication number
- IS3788A7 IS3788A7 IS3788A IS3788A IS3788A7 IS 3788 A7 IS3788 A7 IS 3788A7 IS 3788 A IS3788 A IS 3788A IS 3788 A IS3788 A IS 3788A IS 3788 A7 IS3788 A7 IS 3788A7
- Authority
- IS
- Iceland
- Prior art keywords
- almokalant
- preparation
- methods
- dosage forms
- solid dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9003902A SE9003902D0 (en) | 1990-12-07 | 1990-12-07 | SOLID DOSAGE FORMS OF A DRUG |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS3788A7 true IS3788A7 (en) | 1992-06-08 |
Family
ID=20381121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS3788A IS3788A7 (en) | 1990-12-07 | 1991-12-06 | Methods for the preparation of solid dosage forms containing almokalant |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0560821A1 (en) |
| JP (1) | JPH06503312A (en) |
| CN (1) | CN1063039A (en) |
| AP (1) | AP258A (en) |
| AU (1) | AU8930791A (en) |
| BG (1) | BG97851A (en) |
| CA (1) | CA2097178A1 (en) |
| CZ (1) | CZ103793A3 (en) |
| FI (1) | FI932554L (en) |
| HU (1) | HUT64217A (en) |
| IE (1) | IE914137A1 (en) |
| IL (1) | IL100150A0 (en) |
| IS (1) | IS3788A7 (en) |
| LT (1) | LTIP1717A (en) |
| MA (1) | MA22355A1 (en) |
| MX (1) | MX9102325A (en) |
| MY (1) | MY106776A (en) |
| NO (1) | NO932052L (en) |
| NZ (1) | NZ240731A (en) |
| PT (1) | PT99719A (en) |
| SE (1) | SE9003902D0 (en) |
| SK (1) | SK55693A3 (en) |
| TN (1) | TNSN91117A1 (en) |
| TW (1) | TW215057B (en) |
| WO (1) | WO1992010172A1 (en) |
| YU (1) | YU186891A (en) |
| ZA (1) | ZA919264B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19602757A1 (en) * | 1996-01-26 | 1997-07-31 | Boehringer Mannheim Gmbh | Solid instant release dosage forms and processes for their manufacture |
| GB9611328D0 (en) * | 1996-05-31 | 1996-08-07 | Zeneca Ltd | Pharmaceutical compositions |
| US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| JP4504467B2 (en) * | 1998-07-30 | 2010-07-14 | 佐藤製薬株式会社 | Orally disintegrating tablets |
| JP7426685B2 (en) * | 2018-06-14 | 2024-02-02 | 株式会社東洋新薬 | tablet |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8705150D0 (en) * | 1987-12-23 | 1987-12-23 | Haessle Ab | NOVEL ANTIARRHYTHMIC AGENTS |
| IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it |
| SE8902236D0 (en) * | 1989-06-20 | 1989-06-20 | Haessle Ab | NOVEL POLYSTYRENESULPHONATE |
-
1990
- 1990-12-07 SE SE9003902A patent/SE9003902D0/en unknown
-
1991
- 1991-11-22 ZA ZA919264A patent/ZA919264B/en unknown
- 1991-11-25 IL IL100150A patent/IL100150A0/en unknown
- 1991-11-25 TW TW080109239A patent/TW215057B/zh active
- 1991-11-26 NZ NZ240731A patent/NZ240731A/en unknown
- 1991-11-27 YU YU186891A patent/YU186891A/en unknown
- 1991-11-28 IE IE413791A patent/IE914137A1/en unknown
- 1991-12-02 AP APAP/P/1991/000338A patent/AP258A/en active
- 1991-12-02 MX MX9102325A patent/MX9102325A/en unknown
- 1991-12-03 WO PCT/SE1991/000815 patent/WO1992010172A1/en not_active Ceased
- 1991-12-03 JP JP4500117A patent/JPH06503312A/en active Pending
- 1991-12-03 CZ CS931037A patent/CZ103793A3/en unknown
- 1991-12-03 FI FI932554A patent/FI932554L/en not_active Application Discontinuation
- 1991-12-03 MA MA22639A patent/MA22355A1/en unknown
- 1991-12-03 AU AU89307/91A patent/AU8930791A/en not_active Abandoned
- 1991-12-03 HU HU9301670A patent/HUT64217A/en unknown
- 1991-12-03 EP EP91920708A patent/EP0560821A1/en not_active Withdrawn
- 1991-12-03 SK SK55693A patent/SK55693A3/en unknown
- 1991-12-03 CA CA002097178A patent/CA2097178A1/en not_active Abandoned
- 1991-12-06 MY MYPI91002267A patent/MY106776A/en unknown
- 1991-12-06 TN TNTNSN91117A patent/TNSN91117A1/en unknown
- 1991-12-06 IS IS3788A patent/IS3788A7/en unknown
- 1991-12-06 PT PT99719A patent/PT99719A/en not_active Application Discontinuation
- 1991-12-07 CN CN91112789A patent/CN1063039A/en active Pending
-
1993
- 1993-06-04 BG BG97851A patent/BG97851A/en unknown
- 1993-06-04 NO NO93932052A patent/NO932052L/en unknown
- 1993-12-30 LT LTIP1717A patent/LTIP1717A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BG97851A (en) | 1994-04-29 |
| JPH06503312A (en) | 1994-04-14 |
| LTIP1717A (en) | 1995-07-25 |
| HU9301670D0 (en) | 1993-09-28 |
| PT99719A (en) | 1992-10-30 |
| CN1063039A (en) | 1992-07-29 |
| NO932052D0 (en) | 1993-06-04 |
| CZ103793A3 (en) | 1994-02-16 |
| WO1992010172A1 (en) | 1992-06-25 |
| IL100150A0 (en) | 1992-08-18 |
| ZA919264B (en) | 1992-08-26 |
| TW215057B (en) | 1993-10-21 |
| EP0560821A1 (en) | 1993-09-22 |
| AU8930791A (en) | 1992-07-08 |
| SK55693A3 (en) | 1993-10-06 |
| NO932052L (en) | 1993-06-04 |
| CA2097178A1 (en) | 1992-06-08 |
| HUT64217A (en) | 1993-12-28 |
| SE9003902D0 (en) | 1990-12-07 |
| TNSN91117A1 (en) | 1992-10-25 |
| MX9102325A (en) | 1992-06-01 |
| MA22355A1 (en) | 1992-07-01 |
| FI932554A7 (en) | 1993-06-08 |
| MY106776A (en) | 1995-07-31 |
| NZ240731A (en) | 1993-10-26 |
| AP258A (en) | 1993-06-03 |
| AP9100338A0 (en) | 1992-01-31 |
| FI932554L (en) | 1993-06-08 |
| IE914137A1 (en) | 1992-06-17 |
| YU186891A (en) | 1994-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI905124A0 (en) | Method for the preparation of pyrimidines | |
| FI914174A7 (en) | Process for the preparation of piperidylalkylamines | |
| FI903429A0 (en) | COMPOUND COMPOSITION OF PEPTIDER MED FOERDROEJD FRIGOERING. | |
| NO914429L (en) | PROCEDURE FOR THE PREPARATION OF PIPERIDINYL CAMPERSULPHONYLOXYTOCIN ANTAGONISTS | |
| FI92403B (en) | Method for the preparation of cefodizim disodium | |
| FI95036B (en) | Method for the preparation of thieno-triazolo-diazepine derivatives | |
| NO834729L (en) | PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE TIO-CEPHALOSPORINES | |
| ES536795A0 (en) | PROCEDURE FOR THE PREPARATION OF NONAPEPTIDES AND DODECAPEPTIDES | |
| FI890186A7 (en) | Process for the preparation of 1-hydroxyalkyl-5-nitroimidazoles | |
| NO301716B1 (en) | Process for the preparation of calcium L-ascorbate-2-phosphate | |
| ES2013216A4 (en) | PROCESS FOR THE PREPARATION OF N - PHOSPHONOMETILGLICINA | |
| EE03027B1 (en) | Process for the preparation of 8-chloroquinolone derivatives | |
| FI904570A7 (en) | Method for the preparation of new alkanophenones I | |
| FI890188A7 (en) | Process for the preparation of 1-hydroxyalkyl-2-methyl-5-nitroimidazoles | |
| FI913464A7 (en) | Process for the preparation of 1-hydroxymethylpyrazoles | |
| FI892144A7 (en) | Method for the preparation of 5-C-hydroxymethylaldohexose-based compounds | |
| FI902590A7 (en) | Process for the preparation of 2-oxoindole-1-carboxamides | |
| IT8822524A0 (en) | PROCEDURE FOR THE PREPARATION OF 6-OXOPENICILLANATES | |
| IL100150A0 (en) | Solid dosage forms of almokalant and processes for manufacture thereof | |
| FI940338L (en) | Process for the preparation of 13alpha-cinnamoylbaccatin III or -10-deacetylbaccatin III | |
| NO901422D0 (en) | PROCEDURE FOR THE PREPARATION OF ALFA-GLUCOSIDASE INHIBITORS. | |
| FI911126A0 (en) | Organocuprate method for the preparation of cefprozil | |
| BR8706857A (en) | PROCESSES FOR THE PREPARATION OF MALEIMIDAL COMPOUNDS, THERMOSTENDABLE COMPOUNDS AND WITHOUT THE USE OF AN ORGANOSILIC COMPOUND | |
| FI93363C (en) | New process for the preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates | |
| FI913656A7 (en) | Process for the preparation of alkyl-6-pyridazine derivatives |